Search Results - "Swallow, Diane M. A."

Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study by Swallow, Diane M. A., Counsell, Carl E.

“…Background We conducted a systematic review to identify existing ICD-10 coding validation studies in progressive supranuclear palsy and corticobasal syndrome…”
Get full text

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD) by Swallow, Diane M. A., Counsell, Carl E.

“…Background Misdiagnosis and delayed diagnosis in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are common. Few studies have…”
Get full text

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease by Malek, Naveed, Lawton, Michael A., Swallow, Diane M. A., Grosset, Katherine A., Marrinan, Sarah L., Bajaj, Nin, Barker, Roger A., Burn, David J., Hardy, John, Morris, Huw R., Williams, Nigel M., Wood, Nicholas, Ben-Shlomo, Yoav, Grosset, Donald G.

“…ABSTRACT Objective The purpose of this study was to examine the relationship between vascular disease (and vascular risk factors), cognition and motor…”
Get full text

Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome by Swallow, Diane M.A., Zheng, Cindy S., Counsell, Carl E.

“…ABSTRACT Background High‐quality prevalence studies are important in estimating the burden of disease in a population, thus informing priority setting,…”
Get full text

Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome by Swallow, Diane M.A., Murchie, Peter, Counsell, Carl E.

“…Background Early diagnosis in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) is important for clinical care and key to developing…”
Get full text

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression by Lawton, Michael, Ben-Shlomo, Yoav, May, Margaret T, Baig, Fahd, Barber, Thomas R, Klein, Johannes C, Swallow, Diane M A, Malek, Naveed, Grosset, Katherine A, Bajaj, Nin, Barker, Roger A, Williams, Nigel, Burn, David J, Foltynie, Thomas, Morris, Huw R, Wood, Nicholas W, Grosset, Donald G, Hu, Michele T M

“…ObjectivesTo use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent…”
Get full text

Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study by Tan, Manuela M X, Malek, Naveed, Lawton, Michael A, Hubbard, Leon, Pittman, Alan M, Joseph, Theresita, Hehir, Jason, Swallow, Diane M A, Grosset, Katherine A, Marrinan, Sarah L, Bajaj, Nin, Barker, Roger A, Burn, David J, Bresner, Catherine, Foltynie, Thomas, Hardy, John, Wood, Nicholas, Ben-Shlomo, Yoav, Grosset, Donald G, Williams, Nigel M, Morris, Huw R

“…Our objective was to define the prevalence and clinical features of genetic Parkinson's disease in a large UK population-based cohort, the largest multicentre…”
Get full text

Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease by Lawton, Michael, Hu, Michele T.M, Baig, Fahd, Ruffmann, Claudio, Barron, Eilidh, Swallow, Diane M.A, Malek, Naveed, Grosset, Katherine A, Bajaj, Nin P, Barker, Roger A, Williams, Nigel, Burn, David J, Foltynie, Thomas, Morris, Huw R, Wood, Nicholas W, May, Margaret T, Grosset, Donald G, Ben-Shlomo, Yoav

“…Abstract Background Impaired olfaction is an important feature in Parkinson's disease (PD) and other neurological diseases. A variety of smell identification…”
Get full text

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts by Swallow, Diane M A, Lawton, Michael A, Grosset, Katherine A, Malek, Naveed, Klein, Johannes, Baig, Fahd, Ruffmann, Claudio, Bajaj, Nin P, Barker, Roger A, Ben-Shlomo, Yoav, Burn, David J, Foltynie, Thomas, Morris, Huw R, Williams, Nigel, Wood, Nicholas W, Hu, Michele T M, Grosset, Donald G

“…BackgroundCardiovascular disease (CVD) influences phenotypic variation in Parkinson's disease (PD), and is usually an indication for statin therapy. It is less…”
Get full text

Achieving proportionate governance review in Scotland: Threats and solutions by Swallow, Diane MA, Counsell, Carl E

“…The effectiveness of any healthcare-related research governance system is dependent on its ability to identify, challenge and change practices that compromise…”
Get full text

Nonmotor symptoms in patients without evidence of dopaminergic deficit by Swallow, Diane M. A., Grosset, Katherine A., Grosset, Donald G.

Get full text

Tracking Parkinson's: Study Design and Baseline Patient Data by Malek, Naveed, Swallow, Diane M A, Grosset, Katherine A, Lawton, Michael A, Marrinan, Sarah L, Lehn, Alexander C, Bresner, Catherine, Bajaj, Nin, Barker, Roger A, Ben-Shlomo, Yoav, Burn, David J, Foltynie, Thomas, Hardy, John, Morris, Huw R, Williams, Nigel M, Wood, Nicholas, Grosset, Donald G

“…There is wide variation in the phenotypic expression of Parkinson's disease (PD), which is driven by both genetic and epidemiological influences. To define and…”
Get more information

Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection by Swallow, Diane M A, Lawton, Michael A, Grosset, Katherine A, Malek, Naveed, Smith, Callum R, Bajaj, Nin P, Barker, Roger A, Ben-Shlomo, Yoav, Burn, David J, Foltynie, Thomas, Hardy, John, Morris, Huw R, Williams, Nigel, Wood, Nicholas W, Grosset, Donald G

“…The detection of prodromal Parkinson's disease (PD) is desirable to test drugs with neuroprotective potential, but will be affected by known disease…”
Get more information

Evaluation of a protocol-based treatment strategy for postoperative diabetes insipidus in craniopharyngioma by Pratheesh, Ravindran, Swallow, Diane M A, Joseph, Mathew, Natesan, Damodaran, Rajaratnam, Simon, Jacob, K S, Chacko, Ari G

“…Postoperative diabetes insipidus (DI) is a significant cause of morbidity in craniopharyngiomas (CP) and its effective management improves outcome. The…”
Get full text

Statin usage, vascular diagnosis and vascular risk factors in Parkinson's disease by Cheng, Kelvin Kw, Swallow, Diane Ma, Grosset, Katherine A, Grosset, Donald G

“…Background and aims Vascular disease is a common comorbidity in Parkinson's disease patients. Statins are potentially neuroprotective for Parkinson's disease…”
Get more information

Nonmotor symptoms in patients without evidence of dopaminergic deficit: Nonmotor Symptoms without Dopaminergic Deficit Evidence by Swallow, Diane M. A., Grosset, Katherine A., Grosset, Donald G.

Get full text

EFFECTS OF VASCULAR COMORBIDITY IN PARKINSON'S DISEASE by Swallow, Diane M A, Malek, Naveed, Grosset, Katherine A, Lawton, Michael A, Bajaj, Nin P, Barker, Roger A, Ben-Shlomo, Yoav, Burn, David J, Morris, Huw R, Williams, Nigel, Wood, Nicholas W, Grosset, Donald G

“…Vascular disease and risk factors are common in Parkinson's disease (PD) and may influence phenotype. Statin therapy may thus be indicated. 1759 recently…”
Get full text